Literature DB >> 28391788

Cortical Gray Matter MR Imaging in Multiple Sclerosis.

Massimiliano Calabrese1, Marco Castellaro2.   

Abstract

Several neuropathologic and imaging studies have consistently confirmed that multiple sclerosis affects both white (WM) and gray matter (GM) and that GM damage plays a key role in disability progression. However, differently from WM damage, the less inflammatory cell infiltration, the absence of significant blood-brain barrier damage, the low myelin density in upper cortical layers, as well as technical constraints, make the GM damage almost undetectable by means of conventional MR imaging.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cortical lesions; Gray matter damage; MR imaging; Multiple sclerosis; Normal-appearing gray matter

Mesh:

Year:  2017        PMID: 28391788     DOI: 10.1016/j.nic.2016.12.009

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  9 in total

Review 1.  The tension between early diagnosis and misdiagnosis of multiple sclerosis.

Authors:  Andrew J Solomon; John R Corboy
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

Review 2.  Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.

Authors:  Andrew J Solomon; Robert T Naismith; Anne H Cross
Journal:  Neurology       Date:  2018-10-31       Impact factor: 9.910

Review 3.  MRI and multiple sclerosis--the evolving role of MRI in the diagnosis and management of MS: the radiologist's perspective.

Authors:  Alexis M Cahalane; Hugh Kearney; Yvonne M Purcell; Christopher McGuigan; Ronan P Killeen
Journal:  Ir J Med Sci       Date:  2017-11-25       Impact factor: 1.568

4.  CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis.

Authors:  Damiano Marastoni; Anna I Pisani; Gianmarco Schiavi; Valentina Mazziotti; Marco Castellaro; Agnese Tamanti; Francesca Bosello; Francesco Crescenzo; Giuseppe K Ricciardi; Stefania Montemezzi; Francesca B Pizzini; Massimiliano Calabrese
Journal:  Ther Adv Neurol Disord       Date:  2022-06-21       Impact factor: 6.430

5.  Occulomotor Neural Integrator Dysfunction in Multiple Sclerosis: Insights From Neuroimaging.

Authors:  Peter Bede; Eoin Finegan; Rangariroyashe H Chipika; Stacey Li Hi Shing; Jeffrey Lambe; James Meaney; Janice Redmond
Journal:  Front Neurol       Date:  2018-08-23       Impact factor: 4.003

Review 6.  Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis.

Authors:  Zina-Mary Manjaly; Neil A Harrison; Hugo D Critchley; Cao Tri Do; Gabor Stefanics; Nicole Wenderoth; Andreas Lutterotti; Alfred Müller; Klaas Enno Stephan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-01-25       Impact factor: 10.154

7.  A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4+ CD25high FOXP3+ Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor Recognition.

Authors:  Cody D Moorman; Alan D Curtis; Alexander G Bastian; Sarah E Elliott; Mark D Mannie
Journal:  Front Immunol       Date:  2019-01-10       Impact factor: 7.561

8.  Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis.

Authors:  Jonathan O'Muircheartaigh; Irene Vavasour; Emil Ljungberg; David K B Li; Alexander Rauscher; Victoria Levesque; Hideki Garren; David Clayton; Roger Tam; Anthony Traboulsee; Shannon Kolind
Journal:  Hum Brain Mapp       Date:  2019-01-15       Impact factor: 5.038

Review 9.  Viral infections and multiple sclerosis.

Authors:  Donatella Donati
Journal:  Drug Discov Today Dis Models       Date:  2020-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.